Clinical Trial Update: Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating pharmacokinetics, tolerability, and safety of rifapentine and isoniazid in pregnant and postpartum women with tuberculosis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• rifapentine (rifapentine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-05-06